In two with the three experiments, alprazolam was superior to placebo on a variable outlined as “improve from baseline on the volume of worry attacks each week” (selection, 3.three to five.2), as well as with a phobia score scale. A subgroup of clients who were being enhanced on alprazolam during small-term remedy in one of these trials was con